Top compounds associated with response to ERO1B


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.008
mRNA manumycin A CTRPv2 pan-cancer AAC 0.083 0.008
mRNA BMS-708163 GDSC1000 pan-cancer AAC -0.09 0.008
mRNA ATRA FIMM pan-cancer AAC 0.41 0.008
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.083 0.008
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.008
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.09 0.008
mRNA Cytarabine FIMM pan-cancer AAC -0.42 0.008
mRNA paclitaxel UHNBreast pan-cancer AAC -0.72 0.009
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.009
Download CSV